S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q1 2022

Avoro Capital Advisors

Periodo: Q1 2022 Β· Depositato: 2022-05-16
Vedi su SEC EDGAR β†—
AUM
$5.48B
Valore totale del portafoglio
Posizioni
43
Titoli dichiarati
Prima Posizione
HZNP
12.5% $683.9M
Var. Trimestrali
+4 / -1
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-05-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
HZNPHORIZON THERAPEUTICS PLC$683.9M12.48%β€”β€”
12.5%
UTHRUNITED THERAPEUTICS CORP$543.6M9.92%$179.41$555.91+209.8%
9.9%
APLSAPELLIS PHARMACEUTICALS INC$480.2M8.77%$50.81β€”
8.8%
MRTXMIRATI THERAPEUTICS INC$437.8M7.99%β€”β€”
8.0%
ARGXARGENX SE$395.7M7.22%$315.31$939.68+198.0%
7.2%
XBISPDR SERIES TRUST - S&P BIOTECH$274.1M5.00%$89.31$160.46+79.7%
5.0%
ASNDASCENDIS PHARMA$258.2M4.71%$117.36$274.50+133.9%
4.7%
SRPTSAREPTA THERAPEUTICS INC$244.9M4.47%$78.12$19.28-75.3%
4.5%
BMRNBIOMARIN PHARMACEUTICAL INC$234.0M4.27%$77.10$58.99-23.5%
4.3%
ALNYALNYLAM PHARMACEUTICALS INC$212.3M3.88%$163.29$312.78+91.5%
3.9%
FOLDAMICUS THERAPEUTICS INC$194.1M3.54%β€”β€”
3.5%
SGENSEAGEN INC$189.4M3.46%β€”β€”
3.5%
XENEXENON PHARMACEUTICALS INC$152.4M2.78%$30.57$60.96+99.4%
2.8%
IOVAIOVANCE BIOTHERAPEUTICS INC$151.9M2.77%$16.65$4.31-74.1%
2.8%
MDGLMADRIGAL PHARMACEUTICALS INC$139.8M2.55%$98.12$528.10+438.2%
2.5%
ISEEIVERIC BIO INC$122.0M2.23%β€”β€”
2.2%
KURAKURA ONCOLOGY INC$77.2M1.41%$16.08$11.10-31.0%
1.4%
KRYSKRYSTAL BIOTECH INC$66.9M1.22%$66.54$375.07+463.7%
1.2%
ACADACADIA PHARMACEUTICALS INC$55.1M1.01%$24.22$25.97+7.2%
1.0%
GLUEMONTE ROSA THERAPEUTICS INC$46.4M0.85%$14.02$24.21+72.7%
0.8%
PMVPPMV PHARMACEUTICALS INC$45.8M0.84%$20.82$1.22-94.1%
0.8%
SNDXSYNDAX PHARMACEUTICALS INC$38.6M0.70%$17.38$21.82+25.6%
0.7%
DSGNDESIGN THERAPEUTICS INC$35.9M0.66%$16.15$15.64-3.2%
0.7%
KYMRKYMERA THERAPEUTICS INC$34.5M0.63%$42.32$113.51+168.2%
0.6%
MNKDMANNKIND CORP$32.4M0.59%$3.68$4.52+22.8%
0.6%
CBAYCYMABAY THERAPEUTICS INC$32.0M0.58%β€”β€”
0.6%
WHWKAADI BIOSCIENCES INC$31.0M0.57%$16.97$4.19-75.3%
0.6%
BCRXBIOCRYST PHARMACEUTICLAS INC$30.5M0.56%$16.26$9.84-39.5%
0.6%
MRNSMARINUS PHARMACEUTICALS INC$29.4M0.54%β€”β€”
0.5%
MRSNMERSANA THERAPEUTICS INC$27.1M0.50%β€”β€”
0.5%

AttivitΓ  Trimestre su Trimestre

Q1 2022 vs. Q4 2021

Nuove Posizioni (4)

TickerEmittenteNozionaleDal Deposito
SGENSEAGEN INC$189.4M
BCRXBIOCRYST PHARMACEUTICLAS INC$30.5M-39.5%
RAREULTRAGENYX PHARMACEUTICAL INC$16.7M
AMTIAPPLIED MOLECULAR TRANS INC$7.8M

Posizioni Chiuse (1)

TickerEmittenteNozionale
ARNAARENA PHARMACEUTICALS INC$114.8M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SRPTSAREPTA THERAPEUTICS INC$242.0M+945.0%-75.3%
XBISPDR SERIES TRUST - S&P BIOTECH$156.6M+190.5%+79.7%
KRYSKRYSTAL BIOTECH INC$33.6M+111.6%+463.7%
DICEDICE THERAPEUTICS INC$6.3M+91.1%
PMVPPMV PHARMACEUTICALS INC$12.0M+50.2%-94.1%
KYMRKYMERA THERAPEUTICS INC$-0.4M+48.5%+168.2%
DSGNDESIGN THERAPEUTICS INC$0.9M+35.8%-3.2%
ARGXARGENX SE$57.8M+30.1%+198.0%

Ridotte (4)

TickerEmittenteNozionaleVar. AzioniDal Deposito
HZNPHORIZON THERAPEUTICS PLC$-317.8M-30.1%
NUVLNUVALENT INC$-3.9M-4.8%
MRNSMARINUS PHARMACEUTICALS INC$-9.0M-2.6%
UTHRUNITED THERAPEUTICS CORP$-112.2M-0.2%+209.8%
← Torna agli Hedge Fund